Sandbox: malabsorption: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
{| style="border: 0px; font-size: 100%; margin: 3px;" align="center" | {| style="border: 0px; font-size: 100%; margin: 3px;" align="center" | ||
! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" |Cause | ! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" |Cause | ||
| colspan="7" align="center" style="background:#4479BA; color: #FFFFFF;" |'''Clinical manifestation''' | | colspan="7" align="center" style="background:#4479BA; color: #FFFFFF;" |'''Clinical manifestation''' | ||
Line 12: | Line 11: | ||
! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" |Gold standard diagnosis | ! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" |Gold standard diagnosis | ||
|- | |- | ||
! colspan="6" align="center" style="background:#4479BA; color: #FFFFFF;" |Symptoms | ! colspan="6" align="center" style="background:#4479BA; color: #FFFFFF;" |Symptoms | ||
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Signs | ! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Signs | ||
|- | |- | ||
! colspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Diarrhea | ! colspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Diarrhea | ||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Fever | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Fever | ||
Line 23: | Line 20: | ||
! | ! | ||
|- | |- | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Watery | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Watery | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Bloody | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Bloody | ||
Line 32: | Line 28: | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Other lab findings | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Other lab findings | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Whipple's disease]] | ! align="center" style="background:#DCDCDC;" |[[Whipple's disease]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 65: | Line 60: | ||
* [[PCR]] testing | * [[PCR]] testing | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Celiac disease]] | ! align="center" style="background:#DCDCDC;" |[[Celiac disease]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | ||
Line 99: | Line 93: | ||
* [[IgA]] tissue transglutaminase antibody | * [[IgA]] tissue transglutaminase antibody | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Tropical sprue]] | ! align="center" style="background:#DCDCDC;" |[[Tropical sprue]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 126: | Line 119: | ||
* Diagnosis of exclusion | * Diagnosis of exclusion | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Crohns disease]] | ! align="center" style="background:#DCDCDC;" |[[Crohns disease]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 153: | Line 145: | ||
* [[Colonoscopy]] with [[biopsy]] | * [[Colonoscopy]] with [[biopsy]] | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Ulcerative colitis]] | ! align="center" style="background:#DCDCDC;" |[[Ulcerative colitis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 188: | Line 179: | ||
* [[Colonoscopy]] with [[biopsy]] | * [[Colonoscopy]] with [[biopsy]] | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Cystic fibrosis]] | ! align="center" style="background:#DCDCDC;" |[[Cystic fibrosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 215: | Line 205: | ||
* Elevated [[Sweat chloride test|sweat chloride]] ≥60 mmol/L | * Elevated [[Sweat chloride test|sweat chloride]] ≥60 mmol/L | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[VIPoma]] | ! align="center" style="background:#DCDCDC;" |[[VIPoma]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 249: | Line 238: | ||
* Followed by imaging | * Followed by imaging | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Zollinger-Ellison syndrome]] | ! align="center" style="background:#DCDCDC;" |[[Zollinger-Ellison syndrome]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 272: | Line 260: | ||
* Elevated basal or stimulated serum [[gastrin]]> 120 pg/mL | * Elevated basal or stimulated serum [[gastrin]]> 120 pg/mL | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Eosinophilic gastroenteritis]] | ! align="center" style="background:#DCDCDC;" |[[Eosinophilic gastroenteritis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 298: | Line 285: | ||
* [[Eosinophilic]] infiltration of the [[gastrointestinal tract]] on [[biopsy]] | * [[Eosinophilic]] infiltration of the [[gastrointestinal tract]] on [[biopsy]] | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Primary bile acid malabsorption]] | ! align="center" style="background:#DCDCDC;" |[[Primary bile acid malabsorption]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 321: | Line 307: | ||
* Positive [[SeHCAT]] | * Positive [[SeHCAT]] | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Abetalipoproteinemia]] | ! align="center" style="background:#DCDCDC;" |[[Abetalipoproteinemia]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 349: | Line 334: | ||
* Clinical findings and low [[triglyceride]] and [[cholesterol]] level | * Clinical findings and low [[triglyceride]] and [[cholesterol]] level | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Microscopic colitis]] | ! align="center" style="background:#DCDCDC;" |[[Microscopic colitis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 381: | Line 365: | ||
** [[Lymphocytic]] [[colitis]] is characterized by ≥20 intraepithelial [[lymphocytes]] (IEL) per 100 surface epithelial cells | ** [[Lymphocytic]] [[colitis]] is characterized by ≥20 intraepithelial [[lymphocytes]] (IEL) per 100 surface epithelial cells | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Hyperthyroidism]] | ! align="center" style="background:#DCDCDC;" |[[Hyperthyroidism]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 412: | Line 395: | ||
* [[TSH]] | * [[TSH]] | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Lactose intolerance]] | ! align="center" style="background:#DCDCDC;" |[[Lactose intolerance]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 440: | Line 422: | ||
* [[Lactase]] activity assay | * [[Lactase]] activity assay | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Irritable bowel syndrome]] | ! align="center" style="background:#DCDCDC;" |[[Irritable bowel syndrome]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 461: | Line 442: | ||
* Diagnosis of exclusion | * Diagnosis of exclusion | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Chronic pancreatitis]] | ! align="center" style="background:#DCDCDC;" |[[Chronic pancreatitis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 479: | Line 459: | ||
* [[Secretin]] stimulation test | * [[Secretin]] stimulation test | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Cirrhosis]] | ! align="center" style="background:#DCDCDC;" |[[Cirrhosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 496: | Line 475: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Short bowel syndrome]] | ! align="center" style="background:#DCDCDC;" |[[Short bowel syndrome]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 513: | Line 491: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Intestinal [[lymphoma]] | ! align="center" style="background:#DCDCDC;" |Intestinal [[lymphoma]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 530: | Line 507: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Agammaglobulinemia]] | ! align="center" style="background:#DCDCDC;" |[[Agammaglobulinemia]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 547: | Line 523: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Intestinal [[lymphangiectasia]] | ! align="center" style="background:#DCDCDC;" |Intestinal [[lymphangiectasia]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 564: | Line 539: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Amyloidosis]] | ! align="center" style="background:#DCDCDC;" |[[Amyloidosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 581: | Line 555: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Mastocytosis]] | ! align="center" style="background:#DCDCDC;" |[[Mastocytosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 598: | Line 571: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Small intestinal bacterial overgrowth]] | ! align="center" style="background:#DCDCDC;" |[[Small intestinal bacterial overgrowth]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 615: | Line 587: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Drug induced [[enteritis]] | ! align="center" style="background:#DCDCDC;" |Drug induced [[enteritis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 632: | Line 603: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[HIV AIDS|HIV infection]] | ! align="center" style="background:#DCDCDC;" |[[HIV AIDS|HIV infection]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | |
Revision as of 16:20, 29 November 2017
Abbreviations: WBC: White blood cells; Plt: Platelets, Hgb: Hemoglobin, IgE: Immunoglobulin E, IgA: Immunoglobulin A
Cause | Clinical manifestation | Lab findings | Additional findings | Cause/Pathogenesis | Gold standard diagnosis | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Signs | |||||||||||||
Diarrhea | Fever | Abdominal pain | Weight loss | |||||||||||
Watery | Bloody | Fatty | WBC | Hgb | Plt | Other lab findings | ||||||||
Whipple's disease | + | - | + | ± | + | + |
|
↓ | ↓ | ↓/↑ |
| |||
Celiac disease | ± | - | ± | - | + | + | - | ↓ | - |
|
|
|
||
Tropical sprue | + | - | + | + | + | + |
|
- | ↓ | - |
|
| ||
Crohns disease | + | + | + | + | + | + | ↑ | ↓ | ↑ |
|
|
|
| |
Ulcerative colitis | + | + | + | + | + | + |
|
↑ | ↓ | ↑ |
|
|
|
|
Cystic fibrosis | - | - | + | ± | + | + |
|
- | ↓ | - |
|
|
| |
VIPoma | + | - | + | - | + | + | - | - | - |
|
|
| ||
Zollinger-Ellison syndrome | + | - | + | - | + | + | - | ↓ | - |
|
| |||
Eosinophilic gastroenteritis | + | - | + | - | + | + | ↑ | - | - |
|
|
|
| |
Primary bile acid malabsorption | + | - | + | - | + | + | - | ↓ | - |
|
|
| ||
Abetalipoproteinemia | + | - | + | - | + | + | - | - | - |
|
|
|
| |
Microscopic colitis | + | + | - | - | + | + | - | ↓ | - |
|
|
|
| |
Hyperthyroidism | + | - | - | ± | + | + | - | - | - |
|
||||
Lactose intolerance | + | - | - | - | + | - | - | - | - |
|
|
| ||
Irritable bowel syndrome | ± | - | ± | - | ± | - |
|
- | - | - |
| |||
Chronic pancreatitis | + | - | + | - | + | + |
| |||||||
Cirrhosis | + | - | + | + | + | + | ||||||||
Short bowel syndrome | - | |||||||||||||
Intestinal lymphoma | ||||||||||||||
Agammaglobulinemia | ||||||||||||||
Intestinal lymphangiectasia | ||||||||||||||
Amyloidosis | ||||||||||||||
Mastocytosis | ||||||||||||||
Small intestinal bacterial overgrowth | ||||||||||||||
Drug induced enteritis | ||||||||||||||
HIV infection | ||||||||||||||
Giardiasis | ||||||||||||||
Strongyloidiasis | ||||||||||||||
Tuberculosis |